REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/13/2026
Back to search
Official data from USPTO
XIROMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
XIROMED
ST13
US500000086949502Class
5, 35, 39, 42
Filing
86949502
Registration
6317944
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
04/14/2026
Trademark type
Word
Nice classes
5, 35, 39, 42
Filing date
03/23/2016
Registration date
04/13/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/13/2021
Last transaction
04/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
21
Owner location
MADRID, ES
Examiner
HOWARD, PARKER WALDRIP
Law office
M80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
INSUD PHARMA, S.L.U.
CHEMO ESPAÑA, S.L.
Representatives
Arturo Perez-Guerrero MARCAS ESTADOS UNIDOS
Technical classification
Nice Classes
Class 5Class 35Class 39Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparation for use in treating digestive diseases and disordersgynecological diseases and disordershormonal diseases and disordersblood disorderscancercardiovascular diseasesvascular diseasesgastrointestinal diseasesgenitourinary diseasesimmunologic diseasesinfectious diseasesinflammatory diseasesmetabolic diseases and disorderspsychiatric diseasesmusculoskeletal systemrespiratory systemcirculatory systemviral diseasesglaucomadental and oral diseasesheadachesmigraineobesityhepatic treatmentscholesterolblood pressure and rheumatic treatments; all of the foregoing excluding pharmaceutical preparations for the treatment and/or management of sleep disordersnarcolepsycataplexyand/or excessive daytime sleepiness (EDS); veterinary preparation for treating digestive diseases and disordersgynecological diseases and disordersblood disorderscancercardiovascular diseasesvascular diseasesgastrointestinal diseasesgenitourinary diseasesimmunologic diseasesinfectious diseasesinflammatory diseasesmetabolic diseases and disordersmusculoskeletal systemrespiratory systemcirculatory systemviral diseasesglaucomadental and oral diseasesheadachesmigraineobesityhepatic treatmentscholesterolblood pressure and rheumatic treatments; all of the foregoing excluding pharmaceutical preparations for the treatment and/or management of sleep disordersnarcolepsycataplexyand/or excessive daytime sleepiness (EDS)
Class 35
Sales promotion for othersbusiness management assistancebusiness management consultancy and market research; presentation of goods by any means of communications for retailing purposes; commercial administration of the licensing of the goods and services of others; organisation of exhibitionstrade fairs or congresses for commercial or advertising purposes; all the aforesaid in this class relating to pharmaceutical businesses and for pharmaceutical preparations
Class 39
Distributiondelivery of pharmaceutical preparations; Transportpackaging and storage services for pharmaceutical preparations
Class 42
ChemicalBiological and Pharmaceutical research services; development of pharmaceutical preparations; clinical trial studies of pharmaceutical preparations for others; evaluation and inspection of pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
43 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/09/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/09/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/09/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/14/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/14/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/14/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/14/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/14/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/13/2021
AOUM
ASSIGNMENT OF OWNERSHIP UPDATED MANUALLY
03/22/2021
TMBN
TTAB RELEASE CASE TO TRADEMARKS
03/05/2021
OP.T
OPPOSITION TERMINATED NO. 999999
03/05/2021
OP.D
OPPOSITION DISMISSED NO. 999999
03/05/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/16/2019
OP.I
OPPOSITION INSTITUTED NO. 999999
10/09/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/11/2017
PUBO
PUBLISHED FOR OPPOSITION
04/11/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/22/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/01/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/24/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/24/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/13/2017
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/03/2017
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/03/2017
CNSI
SUSPENSION INQUIRY WRITTEN
02/03/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/27/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/27/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/24/2017
ALIE
ASSIGNED TO LIE
01/23/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/11/2016
GNSL
LETTER OF SUSPENSION E-MAILED
07/11/2016
CNSL
SUSPENSION LETTER WRITTEN
07/11/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
07/11/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/11/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
07/11/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/11/2016
DOCK
ASSIGNED TO EXAMINER
07/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/28/2016
NWAP
NEW APPLICATION ENTERED
03/26/2016
Continuous trademark protection
Get notified about every new filing that threatens XIROMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.